معرفی
James Galloway is Professor of Rheumatology at King's College London, specializing in inflammatory arthritis, autoimmune conditions, and COVID-19 outcomes in rheumatology patients. His research examines biological therapies, treatment disparities, and infection risks in immunocompromised populations.
Current projects include national studies on DMARD utilization patterns, sarcoidosis epidemiology, and malignancy risks associated with immunosuppressive therapies. Leads investigations on ethnic disparities in rheumatologic care using natural language processing methodologies.
۰مقاله منتشرشده
